BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21040992)

  • 1. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.
    Zhao L; Wan Q; Zhou Y; Deng X; Xie C; Wu S
    Radiother Oncol; 2011 Jan; 98(1):23-7. PubMed ID: 21040992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
    Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y; Qin Y; Lang J
    Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Lu J; Ma Y; Chen J; Wang L; Zhang G; Zhao M; Yin Y
    J Radiat Res; 2014 Jan; 55(1):97-104. PubMed ID: 23728319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
    Gai X; Wei Y; Tao H; Zhu J; Li B
    Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
    Chen C; Lin X; Pan J; Fei Z; Chen L; Bai P
    Jpn J Radiol; 2013 Sep; 31(9):593-9. PubMed ID: 23749480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.
    Wang RH; Zhang SX; Zhou LH; Zhang GQ; Yu H; Lin XD; Lin S
    Biomed Mater Eng; 2014; 24(1):1217-25. PubMed ID: 24212016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Wang W; Yang H; Hu W; Shan G; Ding W; Yu C; Wang B; Wang X; Xu Q
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):617-21. PubMed ID: 20138444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis.
    Fung NTC; Hung WM; Sze CK; Lee MCH; Ng WT
    Med Dosim; 2020 Spring; 45(1):60-65. PubMed ID: 31345672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
    Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
    Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of adaptive replanning on adverse reactions and clinical outcome in nasopharyngeal carcinoma treated by helical tomotherapy].
    Yao W; DU L; Ma L; Feng L; Cai B; Xu S; Xie C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):468-75. PubMed ID: 23719523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy.
    Zhang X; Li M; Cao J; Luo JW; Xu GZ; Gao L; Yi J; Huang X; Xiao J; Li S; Dai J
    Br J Radiol; 2012 Aug; 85(1016):e506-13. PubMed ID: 22096217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.
    Niu X; Chang X; Gao Y; Hu C; Kong L
    Radiat Oncol; 2013 Oct; 8():226. PubMed ID: 24083351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients.
    Cheng HC; Wu VW; Ngan RK; Tang KW; Chan CC; Wong KH; Au SK; Kwong DL
    Radiother Oncol; 2012 Sep; 104(3):317-23. PubMed ID: 22551564
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical changes and dosimetric analysis of the neck region based on FBCT for nasopharyngeal carcinoma patients during radiotherapy.
    Chen A; Chen X; Jiang X; Wang Y; Chi F; Xie D; Zhou M
    J Xray Sci Technol; 2024; 32(3):783-795. PubMed ID: 38457140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT.
    Wu Q; Chi Y; Chen PY; Krauss DJ; Yan D; Martinez A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):924-32. PubMed ID: 19801104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China.
    Zhou X; Zhu J; Zhou C; Wang W; Ding W; Chen M; Chen K; Li S; Chen X; Yang H
    Radiat Oncol; 2023 Nov; 18(1):190. PubMed ID: 37974274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.